Compare CSW & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSW | TMDX |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.6B |
| IPO Year | N/A | 2019 |
| Metric | CSW | TMDX |
|---|---|---|
| Price | $262.34 | $129.58 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $321.40 | $152.33 |
| AVG Volume (30 Days) | 126.1K | ★ 757.9K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | ★ 0.40% | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 4.87 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | $23.42 | $24.12 |
| Revenue Next Year | $17.34 | $18.69 |
| P/E Ratio | $40.25 | ★ $28.89 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $230.45 | $62.42 |
| 52 Week High | $337.02 | $156.00 |
| Indicator | CSW | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 33.34 | 42.98 |
| Support Level | $255.91 | $124.45 |
| Resistance Level | $281.14 | $142.44 |
| Average True Range (ATR) | 11.37 | 8.65 |
| MACD | -3.99 | 0.04 |
| Stochastic Oscillator | 3.61 | 8.58 |
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.